Determinants of endothelial dysfunction and carotid intima-media thickness in combined hyperlipidemia

Miran Sebestjen1, Branka Zegura, Viktor Videcnik

  • 1Department of Angiology, Hospital of Internal Medicine, Ljubljana, Slovenia. miran.sebestjen@trnovo.kclj.si

Insights

Apolipoprotein B is linked to both arterial wall function and structure changes in men with hyperlipidemia. Proinflammatory cytokines impact function, while coagulation factors affect structure.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Lipid Metabolism

Background:

  • Atherosclerosis involves early endothelial dysfunction and increased intima-media thickness (IMT).
  • These changes are linked to risk factors, but their association in combined hyperlipidemia requires further study.

Purpose of the Study:

  • To investigate associations between risk factors and arterial wall functional (flow-mediated dilatation, FMD) and morphological (carotid IMT) changes.
  • To identify predictors of FMD and IMT in men with combined hyperlipidemia.

Main Methods:

  • Measured brachial artery FMD and carotid IMT in 72 male patients with combined hyperlipidemia.
  • Assessed serum lipoproteins, coagulation parameters, glucose, and inflammatory markers including C-reactive protein.

Main Results:

  • Tumor necrosis factor-alpha, interleukin 6, and apolipoprotein B independently predicted FMD (explaining 87% of variability).
  • Total tissue factor pathway inhibitor and apolipoprotein B independently predicted increased carotid IMT (explaining 82% of variation).

Conclusions:

  • Apolipoprotein B is associated with both functional and morphological arterial changes.
  • In asymptomatic men with combined hyperlipidemia, functional changes correlate with proinflammatory cytokines, and morphological changes with coagulation parameters.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...